![]() | ![]() From the manuscript Capecitabine-induced leukoencephalopathy involving the bilateral corticospinal tracts ![]() Abstract | ![]() |
![]() | 1. Niemann B, Rochlitz C, Herrmann R, Pless M. Toxic encephalopathy induced by capecitabine. Oncology 2004;66:331–335 ![]() ![]() Find similar topics on ![]() ![]() ![]() 2. Videnovic A, Semenov I. Capecitabine-induced multifocal leukoencephalopathy: a report of five cases. Neurology 2005 Dec 13;65(11):1792-4 ![]() ![]() Find similar topics on ![]() ![]() ![]() 3. Baehring JM, Fulbright RK. Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients. J Neurol Neurosurg Psychiatry 2008 May;79(5):535-9 ![]() ![]() Find similar topics on ![]() ![]() ![]() 4. Endo A, Yoshida Y, Nakashima R, Takahashi N, Tanabe K. Capecitabine induces both cardiomyopathy and multifocal cerebral leukoencephalopathy. Int Heart J 2013;54(6):417-20 ![]() ![]() Find similar topics on ![]() ![]() ![]() 5. Shimoyama R, Ban T. Early diagnosis of capecitabine-induced acute leukoencephalopathy by using diffusion-weighted MRI. Gan To Kagaku Ryoho 2014 Oct;41(10):1251-3 ![]() ![]() Find similar topics on ![]() ![]() ![]() 6. Lyros E, Walter S, Keller I, Papanagiotou P, Fassbender K. Subacute reversible toxic encephalopathy related to treatment with capecitabine: a case report with literature review and discussion of pathophysiology. Neurotoxicology 2014 May;42:8-11 ![]() ![]() Find similar topics on ![]() ![]() ![]() 7. Couch L, Groteluschen DL, Stewart JA, Mulkerin L. Capecitabine-related neurotoxicity presenting as trismus. Clin Colorect Cancer 2003; 3: 121–123 ![]() ![]() Find similar topics on ![]() ![]() ![]() 8. Fantini M, Gianni L. Toxic encephalopathy in elderly patients during treatment with capecitabine: literature review and a case report. J Oncol Pharm Pract 2011 Sep;17(3):288-91 ![]() ![]() Find similar topics on ![]() ![]() ![]() 9. Heier MS, Heintz R, Fossa SD. Passage of 5'-dFUrd and its metabolites 5-FU and 5-FUH2 to CSF in a clinical phase 1 study. Acta Neurol Scand 1986;74:240–4 ![]() ![]() Find similar topics on ![]() ![]() ![]() 10. Nakagawa H, Yamada M, Fukushima M, Ikenaka K. Intrathecal 5-fluoro-2'-deoxyuridine (FdUrd) for the treatment of solid tumor neoplastic meningitis: an in vivo study. Cancer Chemother Pharmacol 1999;43(3):247–56 ![]() ![]() Find similar topics on ![]() ![]() ![]() 11. Han R, Yang YM, Dietrich J, Luebke A, Mayer-Proschel M, Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol 2008;7(4):12 ![]() ![]() Find similar topics on ![]() ![]() ![]() 12. Worms PM. The epidemiology of motor neuron diseases: a review of recent studies.J Neurol Sci. 2001;191(1-2):3 ![]() ![]() Find similar topics on ![]() ![]() ![]() 13. Logroscino G, Traynor BJ. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 2010;81(4):385 ![]() ![]() Find similar topics on ![]() ![]() ![]() 14. Jordan H, Rechtman L, Wagner L, Kaye WE. Amyotrophic lateral sclerosis surveillance in Baltimore and Philadelphia. Muscle Nerve 2015 Jun;51(6):815-21 ![]() ![]() Find similar topics on ![]() ![]() ![]() 15. Chiò A, Logroscino G. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 2013;41(2):118-30 ![]() ![]() Find similar topics on ![]() ![]() ![]() 16. Byrne S, Walsh C. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2011;82(6):623 ![]() ![]() Find similar topics on ![]() ![]() ![]() 17. Chio A, Mora G, Leone M. et al. Early symptom progression rate is related to ALS outcome: a prospective population based study Neurology 20025999–103.103 ![]() ![]() Find similar topics on ![]() ![]() ![]() 18. Norris F, Shepherd R, Denys E. et al. Onset, natural history and outcome in idiopathic adult motor neuron disease J Neurol Sci 199311848–55.55 ![]() ![]() Find similar topics on ![]() ![]() ![]() 19. Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2012;3:CD001447 ![]() ![]() Find similar topics on ![]() ![]() ![]() 20. Qiu JT, Shang XL. Magnetic resonance imaging and diffusion tensor imaging in primary lateral sclerosis. Neurol India 2011;59:767-8 ![]() ![]() Find similar topics on ![]() ![]() ![]() 21. Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria Brain ![]() ![]() Find similar topics on ![]() ![]() ![]() 22. Tartaglia MC, Rowe A, Findlater K, Orange JB, Grace G, Strong MJ. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up. Arch Neurol 2007 Feb ![]() ![]() Find similar topics on ![]() ![]() ![]() 23. Aoki T, Sato T, Hasegawa K, Ishizaki R, Saiki M. Reversible hyperintensity lesion on diffusion-weighted MRI in hypoglycemic coma. Neurology 2004;63:392–93 ![]() ![]() Find similar topics on ![]() ![]() ![]() 24. L Lo, CHA Tan, Umapathi T, CC Lim. Diffusion-Weighted MR Imaging in Early Diagnosis and Prognosis of Hypoglycemia.AJNR June 2006 27: 1222-1224. ![]() ![]() Find similar topics on ![]() ![]() ![]() 25. Seaquist ER, Anderson J. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. J Clin Endocrinol Metab 2013;98(5):1845 ![]() ![]() Find similar topics on ![]() ![]() ![]() 26. Donnelly LA, Morris AD. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med 2005;22(6):749 ![]() ![]() Find similar topics on ![]() ![]() ![]() 27. Loes DJ, Fatemi A. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 2003 Aug 12;61(3):369-74 ![]() ![]() Find similar topics on ![]() ![]() ![]() 28. Bezman L, Moser AB. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 2001;49(4):512 ![]() ![]() Find similar topics on ![]() ![]() ![]() 29. van Wassenaer-van Hall HN, van den Heuvel AG, Jansen GH, Hoogenraad TU, Mali WP. Cranial MR in Wilson disease: abnormal white matter in extrapyramidal and pyramidal tracts. AJNR Am J Neuroradiol 1995 Nov-Dec;16(10):2021-7 ![]() ![]() Find similar topics on ![]() ![]() ![]() 30. Huster D. Wilson disease. Best Pract Res Clin Gastroenterol 2010 Oct;24(5):531-9 ![]() ![]() Find similar topics on ![]() ![]() ![]() 31. Roberts EA, Schilsky ML. American Association for Study of Liver Diseases (AASLD). American Association for Study of Liver Diseases (AASLD) Diagnosis and treatment of Wilson disease: an update ![]() ![]() Find similar topics on ![]() ![]() ![]() 32. Sundal C, Van Gerpen JA. MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology 2012 Aug 7;79(6):566-74 ![]() ![]() Find similar topics on ![]() ![]() ![]() 33. Sundal C, Wszolek Z. Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia. 2012 Aug 30 [Updated 2014 Dec 18] In: Pagon RA, Adam MP, Ardinger HH, et al., editors ![]() ![]() Find similar topics on ![]() ![]() ![]() | ![]() |
![]() | Keyword search: 1. Capecitabine induced leukoencephalopathy 2. corticospinal tracts 3. capecitabine toxicity 4. drug-induced leukoencephalopathy 5. corpus callosum This article belongs to the Neuro section. | ![]() |